Compounds 1, 3–9, and 11 were examined with regard to their nuclear factor kappa B (NF-κB) inhibitory activity in the triple negative breast cancer (TNBC) cell line MDA-MB-231. The gene discussed is NFKB1; the disease is triple-negative breast carcinoma.